Obstetrics & Gynaecology
Top Medical News
4 days ago
Children born to mothers who used acetaminophen during pregnancy do not appear to have poor cognitive development at 4 years of age, as shown in a study.
Stephen Padilla, 4 days ago
Severe dysmenorrhoea, pain related to urinary and gastrointestinal tracts, higher fertility desire and infertility rate are all associated with deep infiltrating endometriosis, according to a Singapore study. On the other hand, heavy menstrual bleeding is predictive of adenomyosis.
4 days ago
Combining continuous glucose monitoring (CGM) with continuous subcutaneous insulin infusion (CSII) therapy helps keep blood glucose levels low throughout pregnancy and lower the rate of large for gestational age (LGA) delivery, according to a study.
6 days ago
Offspring born to mothers with Crohn’s disease (CD), but not ulcerative colitis, are at higher risk of infection, suggests a study. This association is partly mediated by adverse birth outcomes and antitumour necrosis factor α (anti-TNFα) agents.
Add-on vistusertib misses mark in platinum-resistant, refractory ovarian high-grade serous carcinoma
25 Mar 2023
Adding vistusertib to weekly paclitaxel does not appear to help improve clinical outcomes in patients with platinum-resistant or refractory ovarian high-grade serous carcinoma (PR-HGSC), according to the results of a phase II study.
23 Mar 2023
The polyphenol-rich spice cinnamon has the potential to modulate imbalances in lipid profile for certain individuals with metabolic disorders, particularly those with polycystic ovarian syndrome, according to the results of an umbrella meta-analysis.
22 Mar 2023
Dyspareunia, or pain during sexual intercourse, normally occurs after giving birth, but many women do not discuss the condition with their doctors, according to a study. Targeted treatment can help improve this condition.
Dr. Ameet Patki, Dr. Prakash Mayandi, 22 Mar 2022
Recurrent implantation failure (RIF) refers to the failure to achieve a clinical pregnancy after three in vitro fertilization (IVF) attempts with at least four good-quality embryos. RIF leaves couples frustrated and desperate for answers and is challenging for clinicians to handle, compounded by the impact of the COVID-19 pandemic restrictions. Two experts, Dr Ameet Patki, Medical Director of Fertility Associates Mumbai and Hon Assoc Prof at KJ Somaiya Medical College & Hospital, India, and Dr Prakash Mayandi, Metro IVF Fertility Centre, Kuala Lumpur, Malaysia, weigh in with their views on managing RIF during the COVID-19 pandemic.
The changing treatment landscape for premenopausal women with advanced breast cancer: Focus on ribociclib
Dr. Wong Seng Weng, Dr. Lee Guek Eng, 19 Mar 2021
In Singapore, advanced breast cancer (aBC) is the leading cause of cancer death in women 30–49 years of age. For premenopausal women diagnosed with hormone receptor (HR)-positive, HER2-negative BC, cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors provide new hope. Currently, ribociclib is the only CDK4/6 inhibitor studied in the first-line setting for premenopausal women with HR+/HER2- aBC, in the phase III MONALEESA-7 trial. Two experts, Dr Wong Seng Weng, Medical Director & Consultant Medical Oncologist at The Cancer Centre, Paragon Medical & Mount Elizabeth Novena Specialist Centre, and Dr Lee Guek Eng, Senior Consultant & Specialist in Medical Oncology at Icon Cancer Centre and Program Director of the Young Women Cancer Program, weigh in with their views on managing premenopausal women with aBC.
10 Dec 2019
Oral H1-antihistamines are the initial treatment of choice for allergic rhinitis (AR) and chronic urticaria in the primary care setting. However, in a diverse population of patients with AR and urticaria, primary care physicians are faced with the challenge of prescribing the best therapy amid a wide armamentarium of antihistamines available.
01 Sep 2018
Gangliosides and docosahexaenoic acid (DHA) play critical roles in early childhood brain development.
Audrey Abella, 27 Feb 2023
In women with postpartum urinary retention (PUR; bladder volume ≥150 mL) up to 6 hours following vaginal or Caesarean delivery, intermittent catheterization led to quicker time to PUR resolution and was associated with a higher satisfaction rate than continuous catheterization, with no additional complications, a study from Israel reports.
Jairia Dela Cruz, 23 Feb 2023
Further lowering blood pressure helps cut the risk of adverse perinatal events for pregnant women with pregestational diabetes mellitus (DM) and mild chronic hypertension, according to the secondary analysis of the Chronic Hypertension and Adverse Pregnancy (CHAP) study presented at SMFM 2023.
Audrey Abella, 23 Feb 2023
In women undergoing caesarean section (C-section), six scheduled doses of ketorolac reduced postoperative opioid use as opposed to having only two doses.
Elaine Soliven, 23 Feb 2023
Treatment with either labetalol or nifedipine is similarly effective in reducing adverse maternal outcomes among women with mild chronic hypertension (CHTN) in pregnancy, according to a study presented at SMFM 2023.
Jairia Dela Cruz, 22 Feb 2023
Pregnant women may do well to avoid cannabis, with cannabis use in early pregnancy leading to adverse pregnancy outcomes, as reported in a study presented at Society for Maternal-Fetal Medicine (SMFM) 43rd Annual Pregnancy Meeting.
Stephen Padilla, 22 Feb 2023
Pregnant women living with HIV are more likely to achieve viral suppression when treated with dual-nucleoside reverse transcriptase inhibitors (NRTI) in combination with integrase (INSTI) inhibitors compared to protease (PI) inhibitors at delivery, suggests a recent study presented at the 43rd Annual Pregnancy Meeting of the Society for Maternal Fetal Medicine (SMFM 2023).
Elvira Manzano, 22 Feb 2023
Discontinuing oxytocin during the active stage of labour appears safe, according to the STOPOXY trial presented at SMFM 2023.